C Rad AB logo

CRAD B - C Rad AB Share Price

SEK59.4 -0.8  -1.3%

Last Trade - 2:44pm

Small Cap
Market Cap £171.9m
Enterprise Value £163.6m
Revenue £18.8m
Position in Universe 757th / 1831
Unlock CRAD B Revenue
Relative Strength (%)
1m +7.29%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -5.35%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
66.2 82.7 133.1 190.1 205.4 221.6 +27.4%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, C Rad ABrevenues increased 8% to SEK221.6M. Net income applicableto common stockholders totaled SEK14.4M vs. loss ofSEK13.8M. Revenues reflect Asia segment increase of 45% toSEK88.3M, Rest of Europe segment increase of 46% toSEK56.3M, DACH (Germany, Austria, Switzerland) segmentincrease of 9% to SEK34.2M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CRAD B Revenue Unlock CRAD B Revenue

Net Income

CRAD B Net Income Unlock CRAD B Revenue

Normalised EPS

CRAD B Normalised EPS Unlock CRAD B Revenue

PE Ratio Range

CRAD B PE Ratio Range Unlock CRAD B Revenue

Dividend Yield Range

CRAD B Dividend Yield Range Unlock CRAD B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CRAD B EPS Forecasts Unlock CRAD B Revenue
Profile Summary

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since July 23, 2007
No. of Shareholders: 4,121
No. of Employees: 55
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 33,659,302
Free Float (0.0%)
Eligible for
CRAD B Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CRAD B
Upcoming Events for CRAD B
Friday 7th May, 2021
Q1 2021 C Rad AB Earnings Release
Friday 7th May, 2021
Q1 2021 C Rad AB Earnings Call
Thursday 29th July, 2021
Q2 2021 C Rad AB Earnings Release
Thursday 29th July, 2021
Q2 2021 C Rad AB Earnings Call
Thursday 28th October, 2021
Q3 2021 C Rad AB Earnings Release
Thursday 28th October, 2021
Q3 2021 C Rad AB Earnings Call
Frequently Asked Questions for C Rad AB
What is the C Rad AB share price?

As of 2:44pm, shares in C Rad AB are trading at SEK59.4, giving the company a market capitalisation of £171.9m. This share price information is delayed by 15 minutes.

How has the C Rad AB share price performed this year?

Shares in C Rad AB are currently trading at SEK59.4 and the price has moved by 0.103k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the C Rad AB price has moved by 59.13% over the past year.

What are the analyst and broker recommendations for C Rad AB?

Of the analysts with advisory recommendations for C Rad AB, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for C Rad AB is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will C Rad AB next release its financial results?

C Rad AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the C Rad AB dividend yield?

C Rad AB does not currently pay a dividend.

Does C Rad AB pay a dividend?

C Rad AB does not currently pay a dividend.

When does C Rad AB next pay dividends?

C Rad AB does not currently pay a dividend.

How do I buy C Rad AB shares?

To buy shares in C Rad AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of C Rad AB?

Shares in C Rad AB are currently trading at SEK59.4, giving the company a market capitalisation of £171.9m.

Where are C Rad AB shares listed? Where are C Rad AB shares listed?

Here are the trading details for C Rad AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: CRAD B
What kind of share is C Rad AB?

Based on an overall assessment of its quality, value and momentum, C Rad AB is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a C Rad AB share price forecast 2021?

We were not able to load any forecast data for C Rad AB.

How can I tell whether the C Rad AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like C Rad AB. Over the past six months, the relative strength of its shares against the market has been 50.16%. At the current price of SEK59.4, shares in C Rad AB are trading at 33.34% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the C Rad AB PE Ratio?

The C Rad AB PE ratio based on its reported earnings over the past 12 months is 0.139k. The shares are currently trading at SEK59.4.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of C Rad AB?

C Rad AB's management team is headed by:

Tim Thurn - PRE
Peter Hamberg - DRC
Kicki Wallje-Lund - IND
Lars Nyberg - CHM
Asa Hedin - DRC
David Sjostrom - DRC
Hakan Axelsson - COO
Dirk Freynhagen - OTH
Kurt Wang - OTH
Henrik Bergentoft - CFO
Per-Arne Blomquist - DRC
Brian Loar - CEX
Who are the major shareholders of C Rad AB?

Here are the top five shareholders of C Rad AB based on the size of their shareholding:

Svea Ekonomi AB Corporation
Percentage owned: 11.93% (3.92m shares)
Kling (Lars) Individual Investor
Percentage owned: 7.71% (2.54m shares)
Nyberg (Lars) Individual Investor
Percentage owned: 7.49% (2.46m shares)
Nordnet Pensionsforsakring AB Corporation
Percentage owned: 6.07% (2.00m shares)
Avanza Bank Holding AB Corporation
Percentage owned: 5.15% (1.69m shares)
Similar to CRAD B
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.